These findings illustrate a key role of CRNDE in autophagy regulation and sorafenib resistance of HCC cells, suggesting that targeting the CRNDE/ATG4B/autophagy pathway may be a promising strategy to increase the sensitivity of sorafenib in HCC cells. The gene discussed is ATG4B; the disease is hepatocellular carcinoma.